БУХОРО ВИЛОЯТИ ПОПУЛЯЦИЯСИ УРТАСИДА ГЕНДЕР ТАФОВУТИ БЎЙИЧА АЛКОГОЛИ ЖИГАР КАСАЛЛИКЛАРИНИНГ ТАРКАЛИШ ДАРАЖАСИНИ ТАХЛИЛ КИЛИШ

Аннотация

, spiritual and educational journal 11(49)2022 p. 475- 481 27. Nurbaev F.E. Mavlyanov S.I. Pharmacoeconomical analysis of the effectiveness of therapy for chronic hepatitis "C" . Tibbet va sport 2021/No.2 pp.103-108 28. Nurbayev F.E. Pharmacoeconomic analysis of efficiencytherapy chronic hepatits “C” World medicine journal p.152-162 NO 1 (3) 2022y. 29. Nurbaev F.E. Dzhumaev B.Z. “Optimization of modern pharmacotherapy of chronic diffuse liver diseases with predominance of cholestasis syndrome” New Day in medicine 2018. No. 1 27-30 p. 30. Nurbaev F.E. Khamraeva Yu.S., "Pharmacoenomic analysis of the costs of treatment of chronic hepatitis "In" inpatient conditions (Retrospective study)" A New Day in Medicine.2017.No. 4. 38-44 p. 31. Nurbaev.F.E. B.Z.Dzhumaev., "Ways to increase the pharmacoeconomical effectiveness of intrahepatic syndrome therapy." A New Day in Medicine.2017.No. 4.38-44 p. https://scientific-jl.com 2 0 8 64-son_1-to’plam_Iyun-2025